Coya Therapeutics, Inc. is a clinical-stage biotechnology company developing proprietary treatments focused on regulatory T cells (Tregs) to address systemic and neuroinflammation. The company targets conditions such as neurodegenerative, metabolic, and autoimmune diseases.
Some research tools need a free Smallfolk account or a Smallfolk Pro plan.